A Noncanonical Role for Plasminogen Activator Inhibitor Type
A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes Gina M. Coudriet, John Stoops, Anne V. Orr, Bharat Bhushan, Kelly Koral, Sojin Lee, Dana M. Previte, H. Henry Dong, George K. Michalopoulos, Wendy M. Mars, Jon D. Piganelli The American Journal of Pathology Volume 189 Issue 7 Pages 1413 -1422 (July 2019) DOI: 10. 1016/j. ajpath. 2019. 04. 004 Copyright © 2019 American Society for Investigative Pathology Terms and Conditions
Figure 1 The American Journal of Pathology 2019 1891413 -1422 DOI: (10. 1016/j. ajpath. 2019. 04. 004) Copyright © 2019 American Society for Investigative Pathology Terms and Conditions
Figure 2 The American Journal of Pathology 2019 1891413 -1422 DOI: (10. 1016/j. ajpath. 2019. 04. 004) Copyright © 2019 American Society for Investigative Pathology Terms and Conditions
Figure 3 The American Journal of Pathology 2019 1891413 -1422 DOI: (10. 1016/j. ajpath. 2019. 04. 004) Copyright © 2019 American Society for Investigative Pathology Terms and Conditions
Figure 4 The American Journal of Pathology 2019 1891413 -1422 DOI: (10. 1016/j. ajpath. 2019. 04. 004) Copyright © 2019 American Society for Investigative Pathology Terms and Conditions
Figure 5 The American Journal of Pathology 2019 1891413 -1422 DOI: (10. 1016/j. ajpath. 2019. 04. 004) Copyright © 2019 American Society for Investigative Pathology Terms and Conditions
Figure 6 The American Journal of Pathology 2019 1891413 -1422 DOI: (10. 1016/j. ajpath. 2019. 04. 004) Copyright © 2019 American Society for Investigative Pathology Terms and Conditions
Figure 7 The American Journal of Pathology 2019 1891413 -1422 DOI: (10. 1016/j. ajpath. 2019. 04. 004) Copyright © 2019 American Society for Investigative Pathology Terms and Conditions
- Slides: 8